Optimal treatment of cardiovascular disease is essential to decrease mortality among people with diabetes, but information is limited on how actual treatment relates to guidelines. We analysed changes in therapeutic… Click to show full abstract
Optimal treatment of cardiovascular disease is essential to decrease mortality among people with diabetes, but information is limited on how actual treatment relates to guidelines. We analysed changes in therapeutic approaches to anti‐hypertensive and lipid‐lowering medications in people with Type 2 diabetes from 2006 and 2015.
               
Click one of the above tabs to view related content.